| Active Not Recruiting | A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab a Locally Advanced Breast Cancer, Metastatic Breast Cancer | Phase 3 | 2024-08-09 |
| Active Not Recruiting | A Comparative Study of Efficacy and Safety of RPH-002 and Erbitux® in Unresectable Metastatic or Recurrent Hea Head and Neck Squamous Cell Carcinoma | Phase 3 | 2024-08-08 |
| Unknown | Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic S Skin Melanoma | Phase 3 | 2023-09-27 |
| Unknown | Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Skin Melanoma, Squamous Non-small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma | Phase 1 | 2023-03-01 |
| Completed | Efficacy and Safety Evaluation of Refralon®, Concentrate for Solution for Intravenous Injection in Patients Wi Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Atrial Flutter | — | 2022-11-11 |
| Completed | Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19 | Phase 1 / Phase 2 | 2021-09-15 |
| Completed | Study of the Outcomes of Olokizumab Therapy in Hospitalized Patients With SARS-CoV-2 (COVID-19) Infection COVID-19 | — | 2021-07-14 |
| Completed | Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regi COVID-19 | Phase 1 / Phase 2 | 2021-07-13 |
| Unknown | Study of Efficacy of Different Treatment Regimens of Olokizumab COVID-19 | Phase 3 | 2021-07-08 |
| Completed | Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD COVID-19 | Phase 2 | 2021-03-05 |
| Withdrawn | Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard COVID-19 | Phase 2 / Phase 3 | 2020-06-30 |
| Completed | A Phase I Comparative Study of Pharmacokinetics, Safety, and Efficacy of RPH-002 and Erbitux® in Unresectable Head and Neck Squamous Cell Carcinoma | Phase 1 | 2020-06-15 |
| Completed | Study of Efficacy and Safety of TL-FVP-t vs. SOC in Patients With Mild to Moderate COVID-19 COVID-19 | Phase 3 | 2020-05-20 |
| Completed | Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Sofosbuvir in Treatment-naïve Patient Chronic Hepatitis c Genotype 1 | Phase 2 | 2019-05-06 |
| Completed | Pharmacokinetic Equivalence and Safety Study of RPH-001 and Avastin® Healthy | Phase 1 | 2018-07-10 |
| Terminated | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Evaluation of RPH-104 Administered at Different Do Gout Attack | Phase 2 | 2018-03-26 |
| Completed | Efficacy and Safety of All-Oral Combination of Narlaprevir/Ritonavir and Daclatasvir in Treatment-Naїve Patien Chronic Hepatitis C Genotype 1b | Phase 2 | 2017-11-27 |
| Completed | Comparative Clinical Study of Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective General Anaesthesia | Phase 3 | 2017-08-22 |
| Completed | A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral Drugs Healthy | Phase 1 | 2017-04-24 |
| Completed | Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment Overactive Bladder | Phase 3 | 2016-07-18 |
| Completed | Efficacy and Safety of Nemonoxacin vs Levofloxacin in Adult Patients With Community-Acquired Pneumonia Pneumonia, Bacterial | Phase 3 | 2016-05-04 |
| Completed | Pharmacokinetics and Pharmacodynamics of RPH-104 in Healthy Subjects Healthy | Phase 1 | 2016-01-01 |
| Completed | Efficacy and Safety Evaluating Study of Odelepran for the Use in Patient With Alcohol Dependence Alcohol Dependence | Phase 3 | 2014-11-18 |
| Completed | Efficacy and Safety of Narlaprevir Used in Combination With Ritonavir in Treatment-Naïve and Failed Prior Trea Hepatitis C | Phase 3 | 2014-05-07 |
| Completed | Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients W Arterial Hypertension | Phase 3 | 2014-05-01 |
| Completed | A Pharmacokinetic Study of Narlaprevir as a Single Dose or With Ritonavir Combination in Patients With Hepatic Hepatic Impairment | Phase 1 | 2013-11-08 |
| Completed | Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer Stomach Neoplasms | Phase 2 | 2009-11-01 |
| Terminated | A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cance Endometrial Cancer | Phase 3 | 2009-08-01 |
| Completed | Phase I Combination Ixabepilone + Cisplatin Non Small Cell Lung Cancer | Phase 1 | 2009-05-01 |
| Completed | A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmal Advanced/Metastatic Non-Small Cell Lung Cancer | Phase 2 | 2008-12-01 |
| Terminated | Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal G Locally Advanced or Metastatic Breast Cancer | Phase 1 | 2008-06-01 |
| Completed | Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Fema Triple Negative Locally Advanced Non-resectable Breast Cancer, Metastatic Breast Cancer | Phase 2 | 2008-06-01 |
| Completed | Ixabepilone in Combination With Carboplatin in Patients With Non-small Cell Lung Cancer Non-small Cell Lung Cancer (NSCLC) | Phase 1 | 2008-06-01 |
| Terminated | Phase 1 Trial of Oral Ixabepilone Advanced Solid Tumors | Phase 1 | 2008-05-01 |
| Completed | Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2008-05-01 |
| Completed | A Phase I Study of Ixabepilone in Combination With Capecitabine in Japanese Patients With Metastatic Breast Ca Breast Cancer | Phase 1 | 2008-02-01 |
| Terminated | Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast Breast Neoplasms | Phase 2 | 2008-02-01 |
| Completed | A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanc Metastatic Breast Cancer | Phase 2 | 2008-02-01 |
| Completed | A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer Metastatic Breast Cancer | Phase 2 | 2007-03-01 |
| Completed | A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer Metastatic Pancreatic Cancer | Phase 2 | 2007-01-01 |
| Completed | A Phase I Study of Oral Ixabepilone in Subjects With Advanced Cancer Cancer | Phase 1 | 2007-01-01 |
| Completed | A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With Metastatic Breast Cancer | Phase 2 | 2006-12-01 |
| Completed | Phase I Combination w/ Epirubicin Metastatic Breast Cancer | Phase 1 | 2006-08-01 |
| Completed | Ixabepilone Administered as an Enteric Coated Formulation. Cancer | Phase 1 / Phase 2 | 2006-04-01 |
| Completed | Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast C Metastatic Breast Cancer | Phase 2 | 2005-10-01 |
| Completed | Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer Advanced Solid Tumors, Neoplasms | Phase 1 | 2005-09-01 |
| Completed | Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies. Solid Malignancies | Phase 1 | 2005-09-01 |
| Completed | Effect of Capecitabine on the Pharmacokinetics of BMS-247550 and BMS-247550 on the Pharmacokinetics of Capecit Advanced Solid Tumors, Neoplasms | Phase 1 | 2004-10-01 |
| Completed | Study of Ixabepilone (BMS-247550) in Patients With Solid Tumors Solid Tumors | Phase 1 | 2004-04-01 |
| Completed | Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) Breast Cancer, Metastases | Phase 2 | 2004-02-01 |
| Completed | Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Cancer, Breast Cancer | Phase 3 | 2003-11-01 |
| Completed | Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Breast Cancer, Metastases | Phase 3 | 2003-09-01 |
| Unknown | BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast Cancer Breast Cancer | Phase 1 | 2002-09-01 |
| Completed | A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed F Carcinoma, Non-small-cell Lung | Phase 2 | 2001-02-01 |
| Completed | BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1999-07-01 |